IPO Trending
PRAMODINISME / NSEAllotment Awaited

Pramodini Medicare Limited

Pramodini Medicare Limited, incorporated in 2000, is a technology-enabled diagnostic healthcare company providing radiology, clinical laboratory, and nuclear medicine services across India. The company offers a wide range of diagnostic solutions, including MRI, CT scans, X-rays, ultrasound, mammography, pathology, microbiology, biochemistry, PET-CT, SPECT, and nuclear medicine services. It serves government and private hospitals, public sector undertakings (PSUs), medical colleges, and standalone diagnostic centres through multiple partnership models. With a network of diagnostic centres, a 24×7 teleradiology facility, and advanced healthcare technology, Pramodini Medicare focuses on delivering accurate, reliable, and accessible diagnostic services across Tier I, II, and III cities.

₹110 - ₹118GMP ₹03.96x sub
GMPFlat
Est. Listing Price₹118
Review-Analyst Consensus Verdict

Apply

Beacon Capital Advisors Private Limited recommendation is Apply.

Apply
1100%
May Apply
00%
Neutral
00%
Avoid
00%
Not Rated
00%
Brokers / Analysts Review
ReviewerRecommendationReport
Beacon Capital Advisors Private LimitedApplyDownload

Pramodini Medicare Limited IPO Review & Research Verdict (2026)

Financial review and research analysis for Pramodini Medicare Limited (PRAMODINI) IPO. Evaluate company business model strengths, competitive positioning, historical revenue growth, and valuation metrics.

Analyst VerdictApplyBroker Consensus
Company P/EFair ValuePrice to Earnings
Industry P/EPeer BenchmarkListed Competitors
Overall Rating4 / 5Fundamental Score

Explore More About Pramodini Medicare Limited IPO

Frequently Asked Questions (FAQs) - Pramodini Medicare Limited Reviews

Pramodini Medicare Limited IPO Review (2026): Apply or Avoid? Financials & Valuation | IPO Trending